Issue link: https://viewer.e-digitaledition.com/i/748338
Cleveland Clinic's Stanley L . Hazen, MD, PhD, and Universit y Hospita ls' Mukesh Ja in, MD, FA H A , have been elected to t he prestig ious Nationa l Aca demy of Med ici ne (for merly k now n a s t he Institute of Medicine). NA M is a nongovernmenta l organization that is part of the Nationa l Academies of Sciences, Engineering and Medicine. Candidates a re selected based on major contributions to the adva ncement of the medica l sciences, hea lth ca re, a nd public hea lth policies that improve the lives of people a round the world. DR. STANLEY HA ZEN Both a practicing physician and researcher, Dr. Hazen i s t he S ec t ion Hea d for P r e v ent iv e C a r d iolo g y & R ehabi l it at ion i n t he R o b e r t a n d S u z a n n e Tomsich Depa r tment of Cardiovascular Medicine i n t h e M i l l e r H e a r t & Va s c u l a r I n s t i t u t e a t Clevela nd Clinic, a nd the Cha ir of the Depa r tment of Cellula r & Molecula r Medicine in the Lerner Resea rch Institute. He a lso holds the Ja n Bleeksma Cha ir in Va scu la r Cell Biolog y a nd Atherosclerosis a nd the Leona rd Krieger Cha ir in Preventive Ca rdiolog y. Dr. Ha zen ha s ma de pioneer i n g d iscover ies in t he f ields of at herosclerosis a nd inf la m ma- tor y disease resea rch that a re impacting clinica l practice. He made the semina l discover y linking specif ic g ut microbe pathways a nd products to the development of ca rdiovascula r a nd metabolic diseases, including atherosclerosis, thrombosis, hea r t fa ilure a nd chronic kidney disease. In a recent la ndma rk study his resea rch shows d r u g g i n g m icrobi a l pat hw ay s c a n s er ve a s a mea ns for blocking diet-dependent atheroscle- rosis. His comprehensive work establishes a new understa nding of diet/g ut microbe/host interac- tions in diseases, a nd has spawned development of bot h new d ia g nos t ic t es t s a nd t herapeut ic approaches for the treatment a nd prevention of ca rdiovascula r diseases a nd metabolic disorders. Dr. Hazen's numerous other discoveries include defining pathways white blood cells use to generate reactive oxidants, and their functiona l importance in hea r t disease. His work lays the foundation for diagnostic tests in clinica l use for ca rdiovascula r disease risk assessment worldwide. Dr. Hazen has published over 350 peer-reviewed a r ticles, invited reviews a nd book chapters a nd ser ves as reviewer for more tha n 20 scientif ic a nd clinica l journa ls. He ha s received ma ny honors a nd awa rds for his resea rch, including election to the A merica n Societ y for Clinica l Investigation ( A S C I ) a n d t h e A m e r i c a n A s s o c i a t i o n o f Physicia ns (A A P). He a lso is a n elected fellow of the A merica n A ssociation for the Adva ncement of Science (A A AS). Dr. Hazen earned a bachelor's degree and dua l M D/Ph D deg ree from Wa shing ton Universit y School of Medicine in St. Louis, Missouri. He went on to complete an internal medicine residency and fellowship in endocrinolog y diabetes and metabo- lism at Barnes-Jewish Hospita l, a lso in St. Louis. DR. MUKESH JAIN D r. Ja i n i s Un i v e r s i t y Hospita ls Chief Scientif ic Of f icer. A s such, he a lso holds the endowed posi- t ion of Ch ief S cient i f ic O‹cer for the Harrington D i s c o ver y I n s t it ut e a t Universit y Hospita ls in Clevela nd, Oh io — pa r t o f T h e H a r r i n g t o n P r oj e c t f o r D i s c o v e r y & Development — a $300 million internationa l Two NE Ohio Physician-Scientists Named to the National Academy of Medicine 1 0 1 0❱❱❱❱❱ L O C A L D O C S I N N A T I O N A L N E W S